August 14, 2012
A biotechnology unit of Johnson & Johnson on Monday dispensed with the remnants of a False Claims Act case alleging kickbacks to doctors who prescribed anemia drug Procrit after the relator conceded she lacked evidence to support the few allegations left intact after years of litigation.